KIT 1530ins6 Mutation Defines a Subset of Predominantly Malignant Gastrointestinal Stromal Tumors of Intestinal Origin

Human Pathology

Volumn 34, Issue 12, 2003, Pages 1306-1312

  Lasota, Jerzy ^a   Kopczynski, Janusz ^b   Sarlomo Rikala, Maarit ^b   Schneider Stock, Regine ^b   Stachura, Tomasz ^b   Kordek, Radzislaw ^b   Michal, Michal ^b   Boltze, Carsten ^b   Roessner, Albert ^b   Stachura, Jerzy ^b   Miettinen, Markku ^b  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; COLON; DISEASE COURSE; EXON; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GASTROINTESTINAL TUMOR; GENE INSERTION; GENE MUTATION; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; MESENCHYMOMA; METASTASIS; SMALL INTESTINE; SPINDLE CELL; SURVIVAL TIME; TUMOR LOCALIZATION;

EID: 9144241089     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(03)00407-6     Document Type: Article

References (37)

1. Miettinen M, Majidi M, Lasota J: Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): A review. Eur J Cancer 38(Suppl):S39-S51, 2002
2. Yarden Y, Kuang WS, Yang-Fend T, et al: Human proto-oncogene kit, a new cell surface-receptor tyrosine kinase for an unidentified ligand. EMBO J 6:3341-3351, 1987
3. Williams DE, Eisenman J, Baird A, et al: Identification of a ligand for the c-kit proto-oncogene. Cell 63:167-174, 1990
4. Zsebo KM, Williams DA, Geissler EN, et al: Stem cell factor is encoded at the SI locus of the mouse and is ligand for the c-kit tyrosine kinase receptor. Cell 63:214-224, 1990
5. Vliagoftis H, Worobec AS, Metcalfe DD: The proto-oncogene c-kit and c-kit ligand in human disease. J Allergy Clin Immunol 100:435-440, 1997
6. Maeda H, Yamagata A, Nishikawa S, et al: Requirement of c-kit for development of intestinal pacemaker system. Development 116:369-375, 1992
7. Tsuura Y, Hiraki H, Watanabe K, et al: Preferential localization of c-kit product in tissue mast cells, basal cells of skin, epithelial cells of breast, small cell lung carcinoma and seminoma/dysgerminoma in human: Immunohistochemical study of formalin-fixed, paraffin-embedded tissues. Virchows Arch 424:135-141, 1994
8. Sanders KM: A case for interstitial cells of Cajal as pacemakers and mediators of neurotransmission in the gastrointestinal tract. Gastroenterology 111:492-515, 1996
9. Thuneberg L: Interstitial cells of Cajal: Intestinal pacemaker cells? Adv Anat Embryol Cell Biol 71:1-130, 1982
10. Thomsen L, Robinson TL, Lee JCF, et al: Interstitial cells of Cajal generate a rhythmic pacemaker current. Nat Med 4:848-851, 1998
11. Koh SD, Sanders KM, Ward SM: Spontaneous electrical rhythmicity in cultured interstitial cells of Cajal from the murine small intestine. J Physiol (Lond) 513:203-213, 1998
12. Der-Silaphet T, Malysz J, Arsenault AL, et al: Interstitial cells of Cajal direct normal propulsive contractile activity in the small intestine. Gastroenterology 114:724-736, 1998
13. Ward SM, Morris G, Reese L, et al: Interstitial cells of Cajal mediate enteric inhibitory neurotransmission in the lower esophageal and pyloric sphincters. Gastroenterology 115:314-329, 1998
14. Robinson TL, Sircar K, Hewlett BR, et al: Gastrointestinal stromal tumors may originate from a subset of CD34-positive interstitial cells of Cajal. Am J Pathol 156:1157-1163, 2000
15. Vanderwinden JM, Rumessen JJ, De Laet MH, et al: CD34+ cells in human intestine are fibroblast adjacent to, but distinct from, intestinal cells of Cajal. Lab Invest 79:59-65, 1999
16. Kindblom LG, Remotti HE, Aldenborg F, et al: Gastrointestinal pacemaker cell tumor (GIPACK): Gastrointestinal stromal tumors show phenotypic characteristic of the intestinal cells of Cajal. Am J Pathol 132:1259-1269, 1998
17. Sakurai S, Fukasawa T, Chong JM, et al: Embryonic form of smooth muscle myosin heavy chain (SMemb/MHC-B) in gastrointestinal stromal tumor and interstitial cell of Cajal. Am J Pathol 154:23-28, 1999
18. Hirota S, Isozaki K, Moriyama Y, et al: Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279:577-580, 1998
19. Lux ML, Rubin BP, Biase TL, et al: KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors. Am J Pathol 156:791-795, 2000
20. Lasota J, Wozniak A, Sarlomo-Rikala M, et al: Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors. A study of two hundred cases. Am J Pathol 157:1091-1095, 2000
21. Sakurai S, Oguni S, Hironaka M, et al: Mutations in c-kit gene exons 9 and 13 in gastrointestinal stromal tumors among Japanese. Jpn J Cancer Res 92:494-498, 2001
22. Hirota S, Nishida T, Isozaki K, et al: Gain-of-function mutation at the extracellular domain of KIT in gastrointestinal stromal tumours. J Pathol 193;505-510, 2001
23. Antonescu CR, Tschernyavsky SJ, Sommers G, et al: Association of KIT exon 9 mutations with non-gastric primary site and size, and lack of prognostic impact of KIT exon 11 mutations. A clinicopathologic and molecular study of 84 gastrointestinal stromal tumors (GISTs). Mod Pathol 15:10A, 2002
24. Debiec-Rychter M, Lasota J, Sarlomo-Rikala M, et al: Numerical chromosomal aberrations in malignant gastrointestinal stromal tumors: Correlation with c-kit gene mutation. Cancer Genet Cytogenet 121:24-30, 2001
25. Debiec-Rychter M, Pauwels P, Lasota J, et al: Complex genetic alterations in gastrointestinal stromal tumors with autonomic nerve differentiation (GANTs). Mod Pathol 15:692-698, 2002
26. Miettinen M, Furlong M, Sarlomo-Rikala M, et al: Gastrointestinal stromal tumors, intramural leiomyomas and leiomyosarcomas in the rectum and anus: A clinicopathologic, immunohistochemical and molecular genetic study of 144 cases. Am J Surg Pathol 25:1121-1133, 2001
27. Miettinen M, El-Rifai W, Sobin LH, et al: Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: A review. HUM PATHOL 33:466-477, 2002
28. Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, et al: CD117: A sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol 11:728-734, 1998
29. Lasota J, Jasinski M, Sarlomo-Rikala M, et al: Mutations in exon 11 of c-kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas. Am J Pathol 154:53-60, 1999
30. Miettinen M, Sarlomo-Rikala M, Lasota J: KIT expression in angiosarcomas and early fetal endothelial cells and lack of c-kit mutations in angiosarcoma. Mod Pathol 13:536-541, 2000
31. Ernst SI, Hubbs AE, Przygodzki RM, et al: KIT mutation portends poor prognosis in gastrointestinal stromal/smooth muscle tumors. Lab Invest 78:1633-1636, 1998
32. Taniguchi M, Nishida T, Hirota S, et al: Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors. Cancer Res 59:4297-4300, 1999
33. Sakurai S, Fukasawa T, Chong JM, et al: C-kit gene abnormalities in gastrointestinal stromal tumors (tumors of intestitial cells of Cajal). Jpn J Cancer Res 90:1321-1328, 1999
34. Rubin BP, Singer S, Tsao C, et al: KIT activation is a ubiquitous feature of gastrointestinal stromal tumors. Cancer Res 61:8118-8121, 2001
35. Wardelmann E, Neidt I, Bierhoff E, et al: c-kit mutations in gastrointestinal stromal tumors occur preferentially in the spindle rather than in the epithelioid cell variant. Mod Pathol 15:125-136, 2002
36. Corless CL, McGreevey L, Haley A, et al: KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size. Am J Pathol 160:1567-1572, 2002
37. Miettinen M, Kopczynski J, Makhlouf HR, et al: Gastrointestinal stromal tumors, intramural leiomyomas and leiomyosarcomas in the duodenum: A clinicopathologic, immunohistochemical and molecular genetic study of 167 cases. Am J Surg Pathol 27:625-641, 2003